abstract gray background

Archives: Resources

PPD | White Paper
Four ways FSP engagements improve clinical operations productivity and efficiency

Discover how FSP models improve clinical operations productivity, enhance flexibility, and accelerate trial timelines.

Get the white paper
PPD | Webinar
Enhancing clinical efficiency through master protocol trial design

Learn how master protocol trial design accelerates development by evaluating multiple therapies under one streamlined clinical framework.

Read More
PPD | White Paper
Automated MycoSEQ™ Plus Assay: Common and New Approaches in Creating a Mycoplasma-Free Environment

Discover how the MycoSEQ™ Plus assay advances mycoplasma testing with rapid, GMP-compliant PCR detection and expanded species coverage.

Get the white paper
PPD | Report
The Pulse Report 2026
  • External Link

See what 150 global biotech and pharma leaders say about navigating cost, complexity, regulation, AI, and partnerships in 2026.

Access the report
PPD | Overview
Hematology oncology overview brochure
  • External Link

Download our hematology oncology brochure to learn about our specialized approach to hematology oncology studies.

Read the overview
PPD | Report
Harnessing Real-World Data and Evidence to Accelerate Drug Development

Discover ways that RWE accelerates development, de-risks decisions and unlocks real-world success.

Read the report
PPD | White Paper
How is clinical research evolving in IPF and other rare respiratory diseases?

Understand the key considerations shaping IPF and rare respiratory disease trials, from early diagnosis to precision-guided development.

Get the white paper
PPD | White Paper
Transforming Effective Patient Recruitment

Explore modern, data-driven approaches to patient recruitment that improve engagement, speed enrollment, and strengthen clinical trial performance.

Get the white paper
PPD | White Paper
Minimizing Non‑Enrolling Sites to Improve Clinical Trial Outcomes

Explore how targeted site engagement, CRA training, data tools, and PRELs reduce non-enrolling sites, speed enrollment, and strengthen trial outcomes.

Get the white paper